Basic Information
Basic information for SNHG12-209-19aa
Peptide Name SNHG12-209-19aa
Genome Position chr1:28578538-28578584,28579578-28579587[-]
Species Human
Peptide Sequence MELGQSLWEAEGKDPGHFR
Peptide Length 19
Unique No (SNHG12-201-19aa,SNHG12-202-19aa,SNHG12-204-19aa,SNHG12-205-19aa,SNHG12-206-19aa,SNHG12-207-19aa,SNHG12-208-19aa,SNHG12-210-19aa,SNHG12-211-19aa,SNHG12-212-19aa,SNHG12-213-19aa,SNHG12-217-19aa)
Grand Average of Hydropathicity -1.0263
Relative Molecular Mass 2511.67
Experimental Evidences 3:lncORF,m6A,ribo
lncRNA ID/Name ENSG00000197989;SNHG12
Transcript ID/Name ENST00000481368;SNHG12-209
Transcript Length 1800
Coding Ability 0.405
DNA Sequence Corresponding to Peptide ATGGAGTTGGGACAATCTCTATGGGAAGCAGAAGGCAAGGACCCCGGTCATTTTAGG
Experimental Evidences
   lncORF
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :